Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021

/ / News

Pfizer Inc. and its German partner BioNTech SE will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes after the European Commission exercised an option to purchase the extra doses that was granted as part of an agreement signed in November. The move brings the total number of doses to be delivered to the EU to 300 million. The additional 100 million doses will be delivered in 2021. The vaccine is being sold under the name Comirnaty in Europe and will be manufactured at Pfizer’s sites in Europe. The vaccine has been granted emergency use authorization in Europe and the U.S. and is being rolled out in both regions. Pfizer shares were last up 0.3% and have gained 0.5% in 2020. BioNTech ADRs were up 0.04% and have gained 160% in 2020. The SPDR S&P Biotech ETF has gained 50% and the S&P 500 has gained 16%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.